CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
CYNA was delisted on the 20th of October, 2016.
0 hedge funds and large institutions have $0 invested in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 60 closing their positions.
100% less funds holding
Funds holding: 60 → 0 (-60)
100% less funds holding in top 10
Funds holding in top 10: 6 → 0 (-6)
100% less capital invested
Capital invested by funds: $348M → $0 (-$348M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 60
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aisling Capital
New York
|
-$45.1M |
| 2 |
BHMP
Bardin Hill Management Partners
New York
|
-$24M |
| 3 |
CC
Coastland Capital
Palo Alto,
California
|
-$21.3M |
| 4 |
WIC
Water Island Capital
New York
|
-$20.8M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$20.3M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Millennium Management
New York
| – | -$231K | -5,739 | Closed |
|
|
PP
52
Paloma Partners
Greenwich,
Connecticut
| – | -$225K | -5,600 | Closed |
|
|
TI
53
Telemetry Investments
New York
| – | -$214K | -5,311 | Closed |
|
54
Geode Capital Management
Boston,
Massachusetts
| – | -$202K | -5,046 | Closed |
|
55
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$197K | -4,891 | Closed |
|
56
Bank of America
Charlotte,
North Carolina
| – | -$82K | -2,050 | Closed |
|
|
TRCT
57
Tower Research Capital (TRC)
New York
| – | -$42K | -800 | Closed |
|
|
TWA
58
TCI Wealth Advisors
Tucson,
Arizona
| – | -$24K | -600 | Closed |
|
|
NFG
59
Next Financial Group
Houston,
Texas
| – | -$10K | -250 | Closed |
|
|
DOA
60
D'Orazio & Associates
Falls Church,
Virginia
| – | -$2K | -62 | Closed |
|
CYNA Hedge Fund Activity: Q4 2016 in Review
0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) for Q4 2016, worth a combined $0 — down 100% from $348M a quarter earlier.
Sellers outnumbered buyers: 60 funds closed out of CYNA and 0 opened new positions — a net loss of 60 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Aisling Capital, exiting entirely with an estimated $45.1M sold.
- 0 institutional investors held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) as of Q4 2016, down from 60 in Q3 2016.
- Funds reported $0 of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) stock for Q4 2016, down 100% quarter-over-quarter.
- 0 funds opened new CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) positions in Q4 2016 and 60 closed out, a net change of -60 holders.
- The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) seller in Q4 2016 was Aisling Capital, an estimated $45.1M sold.
Based on aggregated 13F filings for Q4 2016.